Literature DB >> 8101106

Antisense oligonucleotides to the p65 subunit of NF-kappa B block CD11b expression and alter adhesion properties of differentiated HL-60 granulocytes.

J A Sokoloski1, A C Sartorelli, C A Rosen, R Narayanan.   

Abstract

NF-kappa B is a pleiotropic regulator of a variety of genes implicated in the cellular response to injury. This function has been attributed to the coordinated binding of subunits of NF-kappa B to distinct regions of the promoter elements of numerous genes, including cytokines, growth factor receptors, and adhesion molecules. Antisense phosphorothioate oligonucleotides to the p50 and p65 subunits of the NF-kappa B complex were used to define the physiologic role of this transcription factor in resting and stimulated granulocytes. A reduction in the expression of p65 was produced by treatment with the phosphorothioate antisense oligodeoxynucleotide. This reduction was accompanied by rapid changes in the cellular adhesion of dimethyl sulfoxide-differentiated HL-60 leukemia cells stimulated by 12-O-tetradecanoylphorbol 13-acetate (TPA). These effects were characterized by a marked reduction in CD11b integrin expression on the surface of treated cells. Furthermore, the p65 antisense oligomer effectively abolished an upregulation of CD11b that was produced by formyl-met-leu-phe and TPA. However, the p65 antisense phosphorothioate oligodeoxynucleotide had no significant effect on the production of reactive oxygen intermediates or on phagocytosis by these cells. These findings indicate that antisense oligomers to p65 can be used to define the role of NF-kappa B in the activation pathways of neutrophils.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8101106

Source DB:  PubMed          Journal:  Blood        ISSN: 0006-4971            Impact factor:   22.113


  22 in total

1.  Inhibition of IL-6 in mice by anti-NF-kappaB oligodeoxyribonucleotide N3'-->oligodeoxyribonnucleotide N3' --> P5' phosphoramidates.

Authors:  L Wang; S Gryaznov; M Nerenberg
Journal:  Inflammation       Date:  1999-12       Impact factor: 4.092

Review 2.  Leukocyte-endothelial cell adhesion: avenues for therapeutic intervention.

Authors:  J Panés; M Perry; D N Granger
Journal:  Br J Pharmacol       Date:  1999-02       Impact factor: 8.739

3.  RANKL expression specifically observed in vivo promotes epithelial mesenchymal transition and tumor progression.

Authors:  Tamaki Yamada; Masumi Tsuda; Tomomi Takahashi; Yasunori Totsuka; Masanobu Shindoh; Yusuke Ohba
Journal:  Am J Pathol       Date:  2011-05-10       Impact factor: 4.307

4.  Differentiation of immortal cells inhibits telomerase activity.

Authors:  H W Sharma; J A Sokoloski; J R Perez; J Y Maltese; A C Sartorelli; C A Stein; G Nichols; Z Khaled; N T Telang; R Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  1995-12-19       Impact factor: 11.205

5.  Inhibition of NF-kappa B-Rel A expression by antisense oligodeoxynucleotides suppresses synthesis of urokinase-type plasminogen activator (uPA) but not its inhibitor PAI-1.

Authors:  U Reuning; O Wilhelm; T Nishiguchi; L Guerrini; F Blasi; H Graeff; M Schmitt
Journal:  Nucleic Acids Res       Date:  1995-10-11       Impact factor: 16.971

6.  Regulation of adhesion and growth of fibrosarcoma cells by NF-kappa B RelA involves transforming growth factor beta.

Authors:  J R Perez; K A Higgins-Sochaski; J Y Maltese; R Narayanan
Journal:  Mol Cell Biol       Date:  1994-08       Impact factor: 4.272

7.  Antisense inhibition of the p65 subunit of NF-kappa B blocks tumorigenicity and causes tumor regression.

Authors:  K A Higgins; J R Perez; T A Coleman; K Dorshkind; W A McComas; U M Sarmiento; C A Rosen; R Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  1993-11-01       Impact factor: 11.205

8.  Induction of carcinoma cell migration on vitronectin by NF-kappa B-dependent gene expression.

Authors:  M Yebra; E J Filardo; E M Bayna; E Kawahara; J C Becker; D A Cheresh
Journal:  Mol Biol Cell       Date:  1995-07       Impact factor: 4.138

9.  Sequence-independent induction of Sp1 transcription factor activity by phosphorothioate oligodeoxynucleotides.

Authors:  J R Perez; Y Li; C A Stein; S Majumder; A van Oorschot; R Narayanan
Journal:  Proc Natl Acad Sci U S A       Date:  1994-06-21       Impact factor: 11.205

10.  PMA withdrawal in PMA-treated monocytic THP-1 cells and subsequent retinoic acid stimulation, modulate induction of apoptosis and appearance of dendritic cells.

Authors:  A Spano; S Barni; L Sciola
Journal:  Cell Prolif       Date:  2013-06       Impact factor: 6.831

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.